Project #74:
Investigating the effect of SGLT2is on COVID-19 outcomes
This study is investigating the use of sodium glucose cotransporter 2 inhibitors (SGLT2is) on the risk of COVID-19 outcomes in the general population.
- Study lead: John Tazare
- Organisation: University of Oxford and London School of Hygiene and Tropical Medicine
- Project type: Research
- Topic area: Risk from COVID (short term) [e.g. hospitalisation/death]